Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia

Dobber, Jos; Latour, Corine; Meijel, Berno van; Riet, Gerben ter; Barkhof, Emile; Peters, Ron J.G.; Reimer, Wilma Scholte op; Haan, Lieuwe de

doi:10.3389/fpsyt.2020.00078

Cited by 18 publications

(14 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mechanisms of change "arguing oneself into change" and "changing self-perceptions" were not tested in this study (Magill et al, 2017). In our previous qualitative study on active ingredients and mechanisms of change in motivational interviewing for medication adherence in a population of patients with schizophrenia (Dobber et al, 2020), we found many clues for the mechanisms of change "arguing oneself into change, " a few for "increasing motivation to change" and one clue for "changing self-perception, " but no clues for "increasing self-efficacy/confidence." It is plausible that self-efficacy plays a more important role in decreasing alcohol use and in smoking cessation than in medication adherence.…”

Section: Discussionmentioning

confidence: 95%

“…oneself into change") (Bem, 1967;Miller, 1983;Gollwitzer, 1999;Miller and Rollnick, 2002, 2004McNally et al, 2005;Moos, 2007;Arkowitz et al, 2008;Gaume et al, 2008;Apodaca and Longabaugh, 2009;Miller and Rose, 2009;Barnett et al, 2010;Glynn and Moyers, 2010;Lee et al, 2010;Berger and Villaume, 2013;Moyers and Miller, 2013;Apodaca et al, 2014;Berger and Bertram, 2015;Copeland et al, 2015;Magill et al, 2015Magill et al, , 2018. In a previous study (Dobber et al, 2020), we performed a systematic literature search for active ingredients and mechanisms of change in PsychInfo, in PubMed, and in textbooks on MI. Based on the research (Gollwitzer, 1999;McNally et al, 2005;Gaume et al, 2008;Apodaca and Longabaugh, 2009;Barnett et al, 2010;Glynn and Moyers, 2010;Lee et al, 2010;Apodaca et al, 2014;Copeland et al, 2015;Magill et al, 2018) and MI theory (Bem, 1967;Miller, 1983;Gollwitzer, 1999;Miller and Rollnick, 2002, 2004McNally et al, 2005;Moos, 2007;Arkowitz et al, 2008;…”

Section: Client Factorsmentioning

confidence: 99%

“…There are a number of candidate active ingredients (e.g., “change talk”) and candidate mechanisms of change, (e.g., “arguing oneself into change”) (Bem, 1967 ; Miller, 1983 ; Gollwitzer, 1999 ; Miller and Rollnick, 2002 , 2004 , 2013 ; McNally et al, 2005 ; Moos, 2007 ; Arkowitz et al, 2008 ; Gaume et al, 2008 ; Apodaca and Longabaugh, 2009 ; Miller and Rose, 2009 ; Barnett et al, 2010 ; Glynn and Moyers, 2010 ; Lee et al, 2010 ; Berger and Villaume, 2013 ; Moyers and Miller, 2013 ; Apodaca et al, 2014 ; Berger and Bertram, 2015 ; Copeland et al, 2015 ; Magill et al, 2015 , 2018 ). In a previous study (Dobber et al, 2020 ), we performed a systematic literature search for active ingredients and mechanisms of change in PsychInfo, in PubMed, and in textbooks on MI. Based on the research (Gollwitzer, 1999 ; McNally et al, 2005 ; Gaume et al, 2008 ; Apodaca and Longabaugh, 2009 ; Barnett et al, 2010 ; Glynn and Moyers, 2010 ; Lee et al, 2010 ; Apodaca et al, 2014 ; Copeland et al, 2015 ; Magill et al, 2018 ) and MI theory (Bem, 1967 ; Miller, 1983 ; Gollwitzer, 1999 ; Miller and Rollnick, 2002 , 2004 , 2013 ; McNally et al, 2005 ; Moos, 2007 ; Arkowitz et al, 2008 ; Gaume et al, 2008 ; Apodaca and Longabaugh, 2009 ; Miller and Rose, 2009 ; Barnett et al, 2010 ; Glynn and Moyers, 2010 ; Lee et al, 2010 ; Berger and Villaume, 2013 ; Moyers and Miller, 2013 ; Apodaca et al, 2014 ; Berger and Bertram, 2015 ; Copeland et al, 2015 ; Magill et al, 2015 , 2018 ...…”

Section: Introductionmentioning

confidence: 99%

“…In a previous study (Dobber et al, 2020 ), we performed a systematic literature search for active ingredients and mechanisms of change in PsychInfo, in PubMed, and in textbooks on MI. Based on the research (Gollwitzer, 1999 ; McNally et al, 2005 ; Gaume et al, 2008 ; Apodaca and Longabaugh, 2009 ; Barnett et al, 2010 ; Glynn and Moyers, 2010 ; Lee et al, 2010 ; Apodaca et al, 2014 ; Copeland et al, 2015 ; Magill et al, 2018 ) and MI theory (Bem, 1967 ; Miller, 1983 ; Gollwitzer, 1999 ; Miller and Rollnick, 2002 , 2004 , 2013 ; McNally et al, 2005 ; Moos, 2007 ; Arkowitz et al, 2008 ; Gaume et al, 2008 ; Apodaca and Longabaugh, 2009 ; Miller and Rose, 2009 ; Barnett et al, 2010 ; Glynn and Moyers, 2010 ; Lee et al, 2010 ; Berger and Villaume, 2013 ; Moyers and Miller, 2013 ; Apodaca et al, 2014 ; Berger and Bertram, 2015 ; Copeland et al, 2015 ; Magill et al, 2015 , 2018 ), we developed a model of hypothetical active ingredients and hypothetical mechanisms of change in the process of MI [see (Dobber et al, 2020 ) for more details]. In the current study, we used this model ( Figure 1 ) to explore coaching strategies and the use of active ingredients to trigger mechanisms of change in MI for smoking cessation in patients with CAD.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Active Ingredients and Mechanisms of Change in Motivational Interviewing for Smoking Cessation in Patients With Coronary Artery Disease: A Mixed Methods Study

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background: For patients with coronary artery disease (CAD), smoking is an important risk factor for the recurrence of a cardiovascular event. Motivational interviewing (MI) may increase the motivation of the smokers to stop smoking. Data on MI for smoking cessation in patients with CAD are limited, and the active ingredients and working mechanisms of MI in smoking cessation are largely unknown. Therefore, this study was designed to explore active ingredients and working mechanisms of MI for smoking cessation in smokers with CAD, shortly after a cardiovascular event.Methods: We conducted a qualitative multiple case study of 24 patients with CAD who participated in a randomized trial on lifestyle change. One hundred and nine audio-recorded MI sessions were coded with a combination of the sequential code for observing process exchanges (SCOPE) and the motivational interviewing skill code (MISC). The analysis of the cases consisted of three phases: single case analysis, cross-case analysis, and cross-case synthesis. In a quantitative sequential analysis, we calculated the transition probabilities between the use of MI techniques by the coaches and the subsequent patient statements concerning smoking cessation.Results: In 12 cases, we observed ingredients that appeared to activate the mechanisms of change. Active ingredients were compositions of behaviors of the coaches (e.g., supporting self-efficacy and supporting autonomy) and patient reactions (e.g., in-depth self-exploration and change talk), interacting over large parts of an MI session. The composition of active ingredients differed among cases, as the patient process and the MI-coaching strategy differed. Particularly, change talk and self-efficacy appeared to stimulate the mechanisms of change “arguing oneself into change” and “increasing self-efficacy/confidence.”Conclusion: Harnessing active ingredients that target the mechanisms of change “increasing self-efficacy” and “arguing oneself into change” is a good MI strategy for smoking cessation, because it addresses the ambivalence of a patient toward his/her ability to quit, while, after the actual cessation, maintaining the feeling of urgency to persist in not smoking in the patient.

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Client Factorsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Active Ingredients and Mechanisms of Change in Motivational Interviewing for Smoking Cessation in Patients With Coronary Artery Disease: A Mixed Methods Study

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…In this literature review, we searched some studies putting a strong emphasis on certain physician interventions leading to improved medication adherence. Motivational interviewing (MI) is one of the most important physician factors in improving medication adherence [30][31][32][33]. A trusting relationship and empathy enable both the physician and the patient to attain depth in the conversation and this fruitful interaction gives opportunities to trigger mechanisms of change of behavior in the patient toward adherence.…”

Section: Schizophreniamentioning

confidence: 99%

Suicidal Behavior and Medication Adherence in Schizophrenic Patients

Warriach¹,

Sanchez-Gonzalez²,

Ferrer³

2021

Cureus

View full text Add to dashboard Cite

Suicide is one of the potential complications in the Schizophrenic patient population. This review article deals with the significance of antipsychotic medication compliance in decreasing suicidal behavior and hospitalizations in Schizophrenic patients. The medication adherence with second-generation antipsychotics (SGA) like clozapine and long-acting injectables (LAIs) like paliperidone is associated with decrease suicidal behavior and all-cause mortality in Schizophrenic patients. Concomitant treatment of depression and substance abuse disorder in this patient population is also associated with decreasing all-cause mortality and hospitalizations. On the other hand, long-term benzodiazepine use is associated with increase mortality in Schizophrenic patients. We also discuss some important physician intervention strategies to improve medication adherence in Schizophrenic patients like motivational interviewing (MI), behavioral tailoring (BT), and psychosocial interventions like cognitive behavior therapy (CBT).

show abstract